Stay updated on Eli Lilly and Company Press Releases
Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest updates to the Eli Lilly and Company Press Releases page
- Check6 days agoChange DetectedNew press releases about Jaypirca trial results and Foundayo availability with pricing were added, while older items and warnings were removed from the page.SummaryDifference8%
- Check13 days agoChange DetectedAdded FDA approval press release for Foundayo (orforglipron) with pricing and home-delivery details. Removed Lilly Employer Connect platform pricing content and the CHMP update for Olumiant.SummaryDifference8%
- Check20 days agoChange DetectedNew press releases have been added, including Lilly to acquire Centessa Pharmaceuticals and recent trial results (Taltz+Zepbound and EBGLYSS). Older releases (e.g., the orforglipron Lancet study) have been removed.SummaryDifference8%
- Check28 days agoChange DetectedFooter and legal/navigation links were added to the press releases page, including cookie settings, privacy policy, terms of use, sitemap, accessibility, and contact information.SummaryDifference100%
- Check35 days agoChange DetectedThe new screenshot shows a blank page where the press releases listing should be; the old screenshot displayed the press releases and related navigation.SummaryDifference28%
- Check42 days agoChange DetectedNew entries for 03/09/2026 (CMMI BALANCE Model update) and 03/05/2026 (Lilly Employer Connect platform) were added, and two older items (Orna Therapeutics acquisition and 2025 Q4 results) were removed from the press releases list.SummaryDifference8%
Stay in the know with updates to Eli Lilly and Company Press Releases
Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.